Israel strikes Iran: Centrifuge site hit, 50 jets involved; why its a big blow to Tehran's nuclear programme TOI World Desk / TIMESOFINDIA.COM / Updated: Jun 19, 2025, 12:16 IST ...

Real estate news: Beckman Coulter campus in Brea up for sale ‘as-is’ Brokers "expect interest from developers of all product types" for the 34-acre site on Kraemer Street.

An office and industrial campus once occupied by biotechnology research company Beckman Coulter Diagnostics has hit the open market. Houston-based real estate company Hines hired Cushman & Wakefield ...

Centrifuge V3 aims to unify real-world asset tokenization across blockchains, and is starting with the $230 million Janus Henderson Anemoy Treasury Fund.

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively ...

Beckman Coulter Life Sciences, a provider of laboratory automation and innovation and an operating company of Danaher Corporation, has launched the CytoFLEX mosaic Spectral Detection Module, the ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k ...

An industry leader in delivering instrument systems, reagents, and services to life science researchers, Beckman Coulter Life Sciences helps enable new discoveries in biology-based research and ...

Beckman Coulter Diagnostics has announced a €10 million investment and 80 jobs. Pictured in its facility in Clare are Michael McGrath, former minister for finance and European Union Commissioner ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and immunoassay analyzer. As healthcare systems ...

In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal antibody-based Alzheimer’s disease therapeutics.